Clinical phenotypes in patients with knee osteoarthritis: a study in the Amsterdam osteoarthritis cohort  by van der Esch, M. et al.
Osteoarthritis and Cartilage 23 (2015) 544e549Clinical phenotypes in patients with knee osteoarthritis: a study in the
Amsterdam osteoarthritis cohort
M. van der Esch y *, J. Knoop y, M. van der Leeden y z x, L.D. Roorda y, W.F. Lems k ¶,
D.L. Knol x#, J. Dekker z x yy
y Amsterdam Rehabilitation Research Center, Reade, Amsterdam, The Netherlands
z VU University Medical Center, Department of Rehabilitation Medicine, Amsterdam, The Netherlands
x VU University Medical Center, EMGO Institute for Health and Care Research, Amsterdam, The Netherlands
k VU University Medical Center, Department of Rheumatology, Amsterdam, The Netherlands
¶ Reade, Department of Rheumatology, Amsterdam, The Netherlands
# VU University Medical Center, Department of Epidemiology and Biostatistics, Amsterdam, The Netherlands
yy VU University Medical Center, Department of Psychiatry, Amsterdam, The Netherlandsa r t i c l e i n f o
Article history:
Received 15 August 2014
Accepted 8 January 2015
Keywords:
Osteoarthritis
Knee [Mesh]
Muscle strength [Mesh]
Phenotype [Mesh]
Obesity [Mesh]
Depressive disorder [Mesh]* Address correspondence and reprint requests to:
Rehabilitation Research Center, Reade, P.O. Box 5827
Netherlands. Tel: 31-20-589-62-91; Fax: 31-20-589-6
E-mail address: m.vd.esch@reade.nl (M. van der E
http://dx.doi.org/10.1016/j.joca.2015.01.006
1063-4584/© 2015 Osteoarthritis Research Society Ins u m m a r y
Objective: To identify and validate previously established phenotypes of knee osteoarthritis (OA) based
on similarities in clinical patient characteristics.
Methods: Knee OA patients (N ¼ 551) from the Amsterdam OA (AMS-OA) cohort provided data. Four
clinical patient characteristics were assessed: upper leg muscle strength, body mass index (BMI),
radiographic severity (Kellgren/Lawrence [KL] grade), and depressive mood (the Hospital Anxiety and
Depression Scale [HADS] questionnaire). Cluster analysis was performed to identify the optimal number
of phenotypes. Differences in clinical characteristics between the phenotypes were analyzed with
ANOVA.
Results: Cluster analysis identiﬁed ﬁve phenotypes of knee OA patients: “minimal joint disease pheno-
type”, “strong muscle strength phenotype”, “severe radiographic OA phenotype”, “obese phenotype”, and
“depressive mood phenotype”.
Conclusions: Among patients with knee OA, ﬁve phenotypes were identiﬁed based on four clinical
characteristics. To a high degree, the results are a replication of earlier ﬁndings in the OA Initiative,
indicating that these ﬁve phenotypes seem a stable, valid, and clinically relevant ﬁnding.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Knee osteoarthritis (OA) is a heterogeneous diseasewith distinct
characteristics during the various stages of disease progression1,2. It
has been hypothesized that knee OA consists of different subgroups
or phenotypes3. To identify subgroups or phenotypes, several ap-
proaches are available, focusing on etiological and risk factors
(metabolic, traumatic, inﬂammatory, and subchondral bone turn-
over)4, focusing on genetic factors5, or focusing on clinical charac-
teristics6. The latter approach seems particularly relevant, as the
ultimate goal of identifying clinical phenotypes is that cliniciansM. van der Esch, Amsterdam
1, 1040 HG Amsterdam, The
3-16.
sch).
ternational. Published by Elsevier Lcan identify and manage subgroups of knee OA patients in their
practices6. There is, however, a paucity of studies identifying clin-
ical, homogenous knee OA subgroups. Most studies focused on a
single clinical characteristics such as pain7, knee malalignment8,
and race and gender9. Only one recent study from our own group
based on data of the OA Initiative (OAI) included several clinical
characteristics at the same time10.
In the last-mentioned study, ﬁve clinically relevant phenotypes
were identiﬁed with data from the open-population-based “pro-
gression subcohort” of the OAI cohort10. These ﬁve phenotypes
were “minimal joint disease phenotype”, “strong muscle pheno-
type”, “non-obese and weak muscle phenotype”, “obese and weak
muscle phenotype”, and “depressive phenotype”. These pheno-
types were based on four patient characteristics i.e., upper leg
muscle strength, body mass index (BMI), radiographic OA, and
depressive mood. The four clinical characteristics are regularlytd. All rights reserved.
Table I
Characteristics of study group (mean and standard deviation, unless otherwise
stated)
Characteristic Mean (SD)
N 551
Age, years 61.7 (8.8)
Gender (% female) 68
Duration of knee symptoms:
Less than 5 years (%) 28
More than 5 years (%) 72
Bilateral knee pain (% yes) 67
Co-occurrence of hip pain (% yes) 15
Number of comorbidities (median and IQR) 2 (1e3)
Muscle strength, Nm 70.3 (35.8)
Body mass index, kg/m2 30.4 (6.2)
Obesity (BMI  30.0) (%) 46
Radiographic knee OA:
K/L score 0 (%) 5
K/L score 1 (%) 32
K/L score 2 (%) 27
K/L score 3 (%) 22
K/L score 4 (%) 14
HADS depressive mood score 4.8 (3.5)
IQR ¼ interquartile range.
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on disease progression and clinical outcome6. In clinical practice,
patients differ highly on these characteristics, necessary for cluster
analysis11.
For reasons of robustness, there is a need to determine whether
the ﬁve phenotypes can be replicated in another sample. The pre-
sent study aimed to identify and validate previously established
phenotypes of knee OA based on similarities in clinical patient
characteristics, i.e., upper leg muscle strength, BMI, radiographic
OA, and depressive mood in patients with knee OA from a clinical
population.
Methods
Patients and methods
The Amsterdam OA (AMS-OA) cohort contains patients with OA
of the knee and/or hip who have been referred to a secondary care
outpatient rehabilitation center (Reade, Center for Rehabilitation
and Rheumatology, Amsterdam, the Netherlands)12. The examina-
tion protocol involves assessments by rheumatologists, radiolo-
gists, and rehabilitation physicians. Demographic, clinical,
radiographic, biomechanical, and psychosocial factors related to OA
were assessed. Total knee replacement, rheumatoid arthritis, or any
other form of inﬂammatory arthritis (i.e., crystal arthropathy or
septic arthritis) were exclusion criteria. In the present study, 551
patients from the AMS-OA cohort with a unilateral or bilateral
diagnosis of knee OA according to the American College of Rheu-
matology (ACR) were included13. The group of patients was deﬁned
as established knee OA due to the combination of conﬁrmed
diagnosis of knee OA according to the ACR criteria and the presence
of knee OA related symptoms making a visit for secondary care
necessary. All patients provided written, informed consent ac-
cording to the Declaration of Helsinki. The study was approved by
the Slotervaart Hospital/Reade Institutional Review Board.
Clustering variables
Muscle strength was used in analyses as the mean score of left
and right lower limb isokinetic muscle strength (quadriceps and
hamstring strength in Newton meters), because the correlation
between left and right muscle strength for extension and ﬂexion
muscle strength was r ¼ .64 and r ¼ .72 (P < .001), respectively14.
BMI was calculated by dividing mass (in kilograms) by squared
height (in meters). Radiographic severity of knee OA (ROA) was
scored by an overall severity grade (Kellgren and Lawrence grade
(KL))15 ranging from 0 to 4, based on weight-bearing ﬁxed-ﬂexion
knee radiograph16. The inter-rater agreement of scoring the
radiographic features was good17. In analysis the most severely
damaged knee was used. Depressive mood was based on the Hos-
pital Anxiety and Depression Scale (HADS) questionnaire, which is
one of the most frequently used questionnaires for depressive
mood experiences with very strong psychometric properties18. The
7-item subscale measures depressive mood on a 4-point response
scale (from 0, no symptoms, to 3, maximum symptoms), with
possible scores for the subscale ranging from 0 to 21. The HADS is a
valid and reliable questionnaire for detecting mood disorder in
people with OA19.
Statistical analysis
Identiﬁcation of subgroups
K-means (or its equivalent “non-hierarchical”) cluster analysis
was used to identify homogeneous subgroups of knee OA patients
(i.e., phenotypes). Cluster analysis is a data analysis technique
aimed at grouping entities on the basis of their similarity withrespect to selected variables. Members of the resulting groups are
as similar as possible to others within their group (high within-
group homogeneity) and as different as possible to those in other
groups (low between-group homogeneity). This analysis implicates
that members are permitted to be member of a single group (i.e.,
phenotype)20. The following clinical characteristics were included
in cluster analysis: mean of left and right lower limb muscle
strength (quadriceps and hamstring strength), BMI, KL grade of the
most severely damaged knee, and score on the HADS questionnaire
(depressive mood) (see Table I for more information). Since cluster
analysis techniques are sensitive to outliers, outlier cases should be
identiﬁed and removed from the dataset before cluster analysis21.
The FASTCLUS procedure of the SAS package22 was used. An esti-
mation of the optimal number of clusters (between three and eight
clusters) was based on the Calinski and Harabasz pseudo F-statis-
tic23, which is the best performing clustering criterion according to
Milligan and Cooper24. Additionally, a second clustering criterion
was used, as recommended by Milligan and Cooper24. This second
criterion was the Beale's F-ratio, which tests the hypothesis of the
existence of an additional cluster vs the already detected clusters25.
The addition of one cluster in the cluster solution should continue
until the hypothesis e tested by Beale's F ratio e was rejected25.
This analysis was continued till the highest pseudo F value was
found, considering that this was the most adequate number of
clusters.
Spearman's correlation coefﬁcients were computed to examine
the bivariate associations between the four clinical characteristics:
muscle strength, KL grade, BMI and HADS scores. Differences of
muscle strength, KL grade, BMI, and HADS scores between the
clusters (phenotypes) were evaluated with analysis of variance
(ANOVA) and a Bonferroni post-hoc analysis.
Results
No outliers were found and therefore a total of 551 patients
were included in the study. The characteristics of the study group
are displayed in Table I. The mean agewas 61.7 (SD ¼ 8.8) years and
68 % of the patients were women. Knee symptoms were present for
more than 5 years in 72% of the patients. Radiographic evidence of
knee OA (i.e., KL grade  2) was found in 63% of the patients. Mean
muscle strength (Nm) and HADS-depressive mood were 70.26
(SD ¼ 35.81) and 4.81 (SD ¼ 3.47), respectively. The mean values of
Table II
Clustering criteria for solution of three or more clusters (ﬁve-cluster solution in
bold)
Number of
clusters
Calinski and
Harabasz F 23
Cluster
comparison
Beale's F
(df*, dfy)25
Beale's
Fp-value26
3 189.23 e e e
4 231.00 3 vs 4 1.46 (43, 274) 0.040
5 232.42 4 vs 5 1.66 (29, 244) 0.030
6 207.13 5 vs 6 0.75 (22, 223) 0.782
Bold formatted numbers showed a signiﬁcant improvement of the model's ﬁt of a
ﬁve-cluster solution compared to a four-cluster and a six-cluster solution.
* numerator degrees of freedom.
y denominator degrees of freedom.
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bilateral radiographic OA: mean (SD) 74.48 (38.68) Nm vs 69.16
(35.07), respectively; P ¼ .193. A BMI  30 was found in 46% of the
study group.
Spearman's correlation coefﬁcients of the four clinical charac-
teristics showed weak associations between muscle strength and
depressive mood (r¼.17, P < .001) and between KL grade and BMI
(r ¼ .12, P ¼ .006). No signiﬁcant associations were found between
KL grade and muscle strength (r ¼ .06; P ¼ .172) and KL grade and
depressive mood (r¼ .07; P¼ .103). No signiﬁcant associations were
found between muscle strength and BMI (r ¼ .06; P ¼ .147), and
between BMI and depressive mood (r ¼ .03; P ¼ .441).
The Calinski and Harabasz pseudo F-statistics and Beale's F-ratio
statistics are shown in Table II. Values of both clustering criteria
were the highest in a ﬁve-cluster solution. Both F-statistics revealed
that a ﬁve-cluster solution showed a signiﬁcant improvement of
the model's ﬁt compared to a four-cluster solution, while a six-
cluster solution did not show a signiﬁcant improvement of the
model's ﬁt compared to a ﬁve-cluster solution. Therefore, the most
adequate number of phenotypes was ﬁve.
The ﬁve identiﬁed phenotypes were named 1. ”minimal joint
disease phenotype”, 2. “strong muscle strength phenotype”, 3.”se-
vere radiographic OA phenotype”, 4. “obese phenotype”, and
5.”depressive mood phenotype”. The four clinical characteristics
(i.e., upper leg muscle strength, BMI, radiographic severity grade,
and depressive mood) of the ﬁve phenotypes and total study group
are shown in Table III.
The differences between the ﬁve phenotypes on each clinical
characteristic are presented in Fig. 1 and displayed in Table III. The
between-subgroup differences were signiﬁcant for muscleTable III
Clinical characteristics of ﬁve identiﬁed phenotypes and total study group in the AMS-O
1: Minimal joint disease
phenotype
2: Strong muscle strength
phenotype
3: Sev
OA ph
n 154 114 116
Isokinetic muscle
strength, Nm
57.0 ± 20.8 124.3 ± 23.1* 53.0 ±
BMI, kg/m2 27.5 ± 4.0 28.8 ± 3.8 29.6 ±
K/L 0e1 69% 22% 0%
K/L 2 31% 35% 0%
K/L 3 0% 31% 55%z
K/L 4 0% 12% 45%z
Depressive mood
(HADS)
3.3 ± 2.0 3.4 ± 2.5 4.0 ±
K/L ¼ Kellgren/Lawrence grade for radiographic severity; BMI ¼ body mass index; HADS
different from other phenotypes and characterize the phenotype.
* Muscle strength was signiﬁcantly different from phenotypes 1, 3, 4, 5. No signiﬁcan
y BMI was signiﬁcantly different from phenotypes 1, 2, 3 and 5. Phenotype 1, 2 an
phenotype 1.
z KL was signiﬁcantly different from phenotypes 1, 2, 4 and 5. No signiﬁcant differenc
x Depressive mood was signiﬁcantly different form phenotypes 1e4. Phenotype 4 w
phenotypes 1e3.strength, F (4, 539) ¼ 192.87, P < .001. Post-hoc analyses (Bonfer-
roni) showed that muscle strength in phenotype 2 was signiﬁcantly
greater than in phenotypes 1, 3, 4, and 5. The between-subgroup
differences were not signiﬁcant for phenotypes 1, 3, 4, and 5. The
between-subgroup differences were signiﬁcant for BMI, F (4,
545) ¼ 159.75, P < .001. Post-hoc analysis showed that BMI in
phenotype 4was signiﬁcantly higher than in phenotypes 1, 2, 3, and
5, while BMI in phenotypes 1, 2, and 5 were not signiﬁcantly
different. BMI of phenotype 3 was signiﬁcantly higher than
phenotype 1, but not higher than BMI of phenotypes 2 and 5. The
between-subgroup differences were signiﬁcant for KL grade, F (4,
537)¼ 155.01, P < .001. Post-hoc analyses showed that the KL grade
in phenotype 3 was signiﬁcantly higher than in phenotypes 1, 2, 4,
and 5. The between-subgroup differences were not signiﬁcant for
phenotypes 1 and 5 and for phenotypes 2 and 4. The KL grade of
phenotypes 2 and 3 was signiﬁcantly different from the KL grade of
phenotypes 1 and 5. The between-subgroup differences were sig-
niﬁcant for the HADS score, F (4,514) ¼ 114.07, P < .001. Post-hoc
analysis showed that the HADS score in phenotype 5 was signiﬁ-
cantly higher than in phenotypes 1, 2, 3, and 4. The HADS score in
phenotype 4 was also signiﬁcantly higher than in phenotypes 1, 2,
and 3, while the HADS scores in phenotypes 1, 2, and 3 were not
signiﬁcantly different.Discussion
The aim of the study was to identify phenotypes based on
similarities in four clinical characteristics in a group of patients
with established knee OA. Cluster analysis showed ﬁve phenotypes:
“minimal joint disease phenotype”, “strong muscle strength
phenotype”, “severe radiographic OA phenotype”, “obese pheno-
type”, and “depressive mood phenotype”.
We used the same four clinical characteristics (i.e., upper leg
muscle strength, BMI, radiographic severity grade, and depressive
mood) as in our previous study on the OAI data10. These four
characteristics were not associated, except for weak associations
between muscle strength and depressive mood and between KL
grade and BMI. Therefore, the association between clinical char-
acteristics did not add statistical noise to the analysis and did not
corrupt the cluster structure25. The present study revealed a ﬁve-
cluster solution, indicating that the optimal number of clusters in
the AMS-OA data as well as in the OAI data was ﬁve10. It can be
claimed with more certainty that the ﬁnding of ﬁve clinicalA cohort
ere radiographic
enotype
4: Obese phenotype 5: Depressive
phenotype
Total study group
81 86 551
22.8 61.2 ± 27.3 55.3 ± 22.8 70.3 ± 35.8
4.3 41.3 ± 5.0y 28.5 ± 4.4 30.4 ± 6.2
31% 56% 37%
35% 37% 27%
23% 7% 22%
11% 0% 14%
2.7 5.2 ± 3.4 10.2 ± 2.3x 4.8 ± 3.5
¼ Hospital Anxiety and Depression Scale. Bold formatted numbers are signiﬁcantly
t difference between phenotypes 1, 3, 4, 5.
d 5 were not signiﬁcantly different, phenotype 3 was signiﬁcantly different from
e between phenotypes 1 and 5 and between phenotypes 2 and 4.
as signiﬁcantly different from phenotypes 1e3. No signiﬁcant difference between
Fig. 1. Comparison of the ﬁve phenotypes on each clinical characteristic. A. Isokinetic muscle strength (Nm). Phenotype 2 was signiﬁcantly different (P < .001) from phenotypes 1, 3,
4, and 5. B. BMI. Phenotype 4 was signiﬁcantly different (P < .001) from phenotypes 1, 2, 3, and 5. Phenotype 3 was signiﬁcantly different from 1, 2 and 5 (P < .05). C. Radiographic
OA: Kellgren/Lawrence (0e4). Phenotype 3 was signiﬁcantly different (P < .001) from phenotypes 1, 2, 4, and 5. Phenotypes 2 and 4 were signiﬁcantly different from 1 to 5 (P < .001).
D. HADS questionnaire: depressive mood). Phenotype 5 was signiﬁcantly different (P < .001) from phenotypes 1, 2, 3, and 4. Phenotype 4 was signiﬁcantly different from phenotypes
1, 2, and 3 (P < .05). Phenotypes: 1 ¼ “minimal joint disease”, 2 ¼ “strong muscle strength”, 3 ¼ “severe radiographic OA”, 4 ¼ “obese”, 5 ¼ “depressive mood”. Error bars: 95% CI.
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ﬁnding by chance, but a deﬁnitive, repeatable result.
The clinically heterogeneous population of knee OA patients
seems to exist of ﬁve homogeneous subgroups of patients. The
clinical characteristics can be used to interpret these ﬁve pheno-
types. The “minimal joint disease” phenotype is a subgroup
without prominent clinical or radiological characteristics, despite
the symptoms necessitating a visit to a second care rehabilitation
center and despite the clinically diagnosed OA. The “strong muscle
strength” phenotype is a subgroup with high muscle strength as
most prominent characteristic, and relatively more radiographic
severity. The “severe radiographic OA” phenotype is a subgroup
with degeneration of cartilage and bone as most prominent char-
acteristic. The “obese” phenotype is a subgroup with high BMI as
most prominent characteristic, and relatively severe radiographic
OA and relatively high depressive mood (HADS). Finally, the
“depressive mood phenotype” is a subgroup with depressive mood
as themost prominent characteristic, irrespective of the other three
characteristics.The ﬁndings are to a large extent similar to what was found by
our research group in the OAI cohort. Both studies had similar
“minimal joint disease”, “strong muscle strength”, and “depressive
mood” phenotypes. In the OAI study, the “severe radiographic OA”
phenotype was named the “non-obese and weak muscle strength”
phenotype, while the “obese” phenotype was named the “obese
and weak muscle strength” phenotype. The renaming of these two
phenotypes (“non-obese and weak muscle strength” into “severe
radiographic OA”, and “obese and weak muscle strength” into
“obese”) was respectively based on the more pronounced appear-
ance of radiographic OA and BMI characteristics in the current
study. The difference in phenotypes might be a real difference, but
could also be explained by a change in interpretation of the data,
primarily based on advancing insight. Taking into account the re-
sults of the current study, the data of the OAI study were re-
analyzed. We noticed that the “non-obese and weak muscle”
phenotype of the OAI study also showed more extent of OA
radiographic severity10, and that in the “obese and weak muscle”
phenotype, muscle strength was not signiﬁcantly different from the
M. van der Esch et al. / Osteoarthritis and Cartilage 23 (2015) 544e549548other phenotypes10. Therefore, these two phenotypes could have
been labeled as “severe radiographic OA” and “obese” phenotype as
well.
In general, knee OA patients will beneﬁt from muscle
strengthening exercises26,27. Based on the results, however, we
believe that segregating patients on four clinical characteristics into
ﬁve phenotypes may help in ﬁnding the best targeted personalized
care in knee OA. Theoretically, patients within the “minimal joint
disease” phenotype may need a treatment approach including
education, pain coping skill training, and self-management, as has
been used in chronic pain conditions28,29. For patients within the
“strong muscle strength” phenotype, appropriate education and
pain medication might be a targeted solution30e32, and muscle
strengthening exercises would not be the treatment of ﬁrst choice.
Although the inﬂuence of structural degradation in the indication
for surgery in OA is controversial, the “severe radiographic OA”
phenotypemight help physicians and surgeons inmaking decisions
for surgery33. Patients of the “obese” phenotype may need dietary
changes, alongside to exercise therapy34. Additionally, attention for
a slightly increased depressive mood might also be included in the
treatment approach for the “obese” phenotype. Finally, patients of
the “depressive mood” phenotype may beneﬁt from treatment for
their depressive mood, alongside their OA speciﬁc manage-
ment35,36. These speculations on targeted personalized care in knee
OA need to be tested in randomized controlled trials in patients
with predeﬁned phenotypes before being applied in clinical care.
The choice of clinical characteristics included in the cluster
analysis may affect the results. We used upper leg muscle strength,
BMI, severe radiographic OA, and depressive mood to identify
clinical phenotypes. Other phenotypes could have been found had
other clinical characteristics been included in the analysis. Biome-
chanical characteristics (e.g., knee alignment, joint stability), bone
involvement, clinical synovitis, or psychosocial characteristics
(anxious mood, self-efﬁcacy) could have been included in cluster
analyses, potentially yielding other phenotypes4. The four included
clinical characteristics, however, are easy to diagnose, with simple
assessment measurements6. In identifying meaningful phenotypes
the compartmental difference between tibiofemoral OA and
patellofemoral OA might also be important37. The KL grading de-
pends on scoring the radiographic features of the tibiofemoral
compartments and not on scoring of the features of the patellofe-
moral compartment. Future phenotype studies should account for
the difference in compartmental grading.
A potential limitation of the study is the cross-sectional design:
longitudinal follow-up of phenotypes is interesting for examining
the stability of the clusters found over time. Longitudinally, patients
might change from phenotype, showing changes in disease tra-
jectories. Knowledge on the change in membership of a phenotype
over time is important for causal reasons and has implications for
personalized care. Therefore, longitudinal studies are needed to test
the stability of the clusters over time and the membership of pa-
tients to these clusters over time. Furthermore, whereas cluster
analysis is an objective means for the subgrouping of patients with
knee OA, its potential shortcomings must be kept in mind. One of
the shortcomings is that no accepted criterion to determine the
number of clusters and the sample size of patients exists. In our
study, however, both the pseudo F-statistic and Beale's F-ratio
statistic indicated that the ﬁve-cluster solution was the best solu-
tion. Regarding minimum sample size of patients, there is no
generally accepted rule of thumb. The objective of cluster analysis is
to construct internally homogeneous and clearly distinct clusters.
We used a limited set of four clinical characteristics in a population
of 551 patients: this resulted in internally homogeneous and clearly
distinctable clusters. Finally, a limitation is the setting of patient
recruitment of this cohort in one secondary care rehabilitationcenter. Large cohorts, containing detailed information on patients
recruited in multiple settings are costly to establish. An option
could be tomergemultiple cohorts obtained in different settings on
comparable clinical characteristics, to ensure representation of
different phenotypes of patients.
In conclusion, among patients with knee OA, ﬁve phenotypes
were identiﬁed based on four clinical characteristics. To a high
degree, the results are a replication of earlier ﬁndings in the OAI.
The ﬁve phenotypes seem a stable, valid, and clinically relevant
ﬁnding.
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